Like this article?
Get your free daily medical news from Physician's First Watch.
FDA Advisers: HPV Vaccine Should Be Approved for Use in Boys, Young Men
An FDA advisory panel recommended on Wednesday that the quadrivalent human papillomavirus vaccine (Gardasil) be approved to prevent genital warts in males ages 9 through 26, according to the Wall Street Journal. The vaccine is currently approved for use in females of the same age.
Earlier in the day, the panel endorsed approval of a bivalent HPV vaccine (Cervarix) for use in females ages 10 through 25.
Wall Street Journal story (Free)
Gardasil prescribing information (Free PDF)
Published in Physician's First Watch September 10, 2009
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.